fair scrutiny and observation based opinion should be allowed... were here to talk about the performance of the stock...they are the biggest part of that they are not a law unto their own.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025